Efficacy of neuraminidase (NA) inhibitors against H1N1 strains of different geographical regions: An in silico approach

Indian Journal of Microbiology

Volumn 49, Issue 4, 2009, Pages 370-376

  Khan, Asad U ^a   Shakil, Shazi ^a   Lal, Sunil K ^b  

^a ALIGARH MUSLIM UNIVERSITY   (India)

^b INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

H1N1; NA inhibitor; Neuraminidase; Swine flu

Indexed keywords

SUIDAE;

EID: 73549109211     PISSN: 00468991     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12088-009-0065-2     Document Type: Article

References (16)

1. Shinde V, Bridges CB, Uyeki TM, Shu B, Balish A, Xu X, Lindstrom S, Gubareva LV, Deyde V, Garten RJ, Harris M, Gerber S, Vagasky S, Smith F, Pascoe N, Martin K, Dufficy D, Ritger K, Conover C, Quinlisk P, Klimov A, Bresee JS and Finelli L (2009) Triple-reassortant swine influenza A (H1) in humans in the United States, 2005-2009 N Engl J Med 360: 2616-2625.
2. Schulze IT (1972) The structure of influenza virus. II. A model based on the morphology and composition of subviral particles. Virology 47: 181-196.
3. Lamb RA and Choppin PW (1983) The structure and replication of influenza virus. Ann Rev Biochem 52: 467-506.
4. Anwar T and Khan AU (2006) Matrix protein 1: A comparative in silico study on different strains of influenza A H5N1 Virus. Bioinformation 1: 253-256.
5. Webster RG, Bean WJ, Gorman OT, Chambers TM and Kawaoka Y (1992) Evolution and ecology of influenza A viruses. Microbiol Rev 56: 152-179.
6. Abed Y and Boivin G (2006) Treatment of respiratory virus infections. Antiviral Res 70: 1-16.
7. DeGoey DA, Chen HJ, Flosi WJ, Grampovnik DJ, Yeung CM, Klein LL and Kempf DJ (2002) Enantioselective synthesis of antiinfluenza compound A-315675. J Org Chem 67: 5445-5453.
8. Kati WM, Montgomery D, Carrick R, Gubareva L, Maring C, McDaniel K, Steffy K, Molla A, Hayden F, Kempf D and Kohlbrenner W (2002) In vitro characterization of A-315675, a highly potent inhibitor of A and B strain influenza virus neuraminidases and influenza virus replication. Antimicrob Agents Chemother 46: 1014-1021.
9. Hayden FG, (1997) Antivirals for pandemic influenza. J Infect Dis 176Suppl 1: S56-61.
10. Ison MG, Gubareva LV, Atmar RL, Treanor J and Hayden FG (2006) Recovery of drug-resistant influenza virus from immunocompromised patients: a case series. J Infect Dis 193: 760-764.
11. Normile D and Enserink M (2007) Avian influenza. With change in the seasons, bird flu returns. Science 315: 448.
12. Le QM, Kiso M, Someya K, Sakai YT, Nguyen TH, Nguyen KH, Pham ND, Ngyen HH, Yamada S, Muramoto Y, Horimoto T, Takada A, Goto H, Suzuki T, Suzuki Y and Kawaoka Y (2005) Avian flu: isolation of drug-resistant H5N1 virus. Nature 437: 1108.
13. Arnold K, Bordoli L, Kopp J, Schwede T (2006) The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics 22: 195-201.
14. Laskowski RA, Chistyakov VV and Thornton JM (2005) PDBsum more: new summaries and analyses of the known 3D structures of proteins and nucleic acids. Nucleic Acids Res 33 (Database issue): D266-268.
15. Eisenberg DR, Lüthy R and Bowie JU (1997) [20] VERIFY3D: Assessment of protein models with three-dimensional profiles Meth Enzymol 277: 396-404.
16. Sheu TG, Deyde VM, Okomo-Adhiambo M, Garten RJ, Xu X, Bright RA, Butler EN, Wallis TR, Klimov AI and Gubareva LV (2008) Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008. Antimicrob Agents Chemother 52: 3284-3292.